Skip to main content Accessibility help

An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project

  • Juanita Westbury (a1), Shane Jackson (a1), Peter Gee (a1) and Gregory Peterson (a1)


Background: This study evaluated a multi-faceted, interdisciplinary intervention to reduce the use of benzodiazepines and antipsychotics in nursing homes – the “RedUSe” (Reducing Use of Sedatives) project.

Methods: The RedUSe project was a controlled trial conducted in 25 nursing homes in Tasmania, with 13 intervention and 12 control homes. A series of pharmacist-led strategies were provided to intervention homes including two medication audit and feedback cycles, educational sessions for staff and an interdisciplinary sedative review. Data on psychotropic drug use at each nursing home were collected utilizing a customized computer program at baseline, 12 and 26 weeks. The RedUSe project was registered as a controlled trial at the Australian New Zealand Clinical Trials Registry, registration number: ACTRN12608000221358.

Results: For each measure, an average of 1591 residents were audited. Over the six-month trial, there was a significant reduction in the percentage of intervention home residents regularly taking benzodiazepines (31.8% to 26.9%, p < 0.005) and antipsychotics (20.3% to 18.6%, p < 0.05), whereas control home psychotropic use did not alter significantly. For residents taking benzodiazepines and antipsychotics at baseline, there were significantly more dose reductions/cessations in intervention homes than in control homes (benzodiazepines: 39.6% vs. 17.6%, p < 0.0001; antipsychotics: 36.9% vs. 20.9%, p < 0.01).

Conclusions: RedUSe led to a significant reduction in the proportion of residents in nursing homes taking benzodiazepines and antipsychotics, and a significant increase in the number of dose reductions of these agents. Our findings suggest that a multi-faceted program, coordinated through a community pharmacy, can offer an effective approach in reducing psychotropic use in nursing homes.


Corresponding author

Correspondence should be addressed to: Juanita Westbury MSc, BPharm, University of Tasmania, Unit of Medication Outcomes Research and Education, School of Pharmacy, Private Bag 83, Hobart, Tasmania 7001. Phone: +61 3 6226 1966; Fax: +61 3 6226 7627. Email:


Hide All
American Psychiatric Association (2007). American Psychiatric Association. Practice Guideline for the Treatment of Patients with Alzheimer's Disease and Other Dementias. 2nd edn. Available at: (last accessed 11 November 2008).
Australian Pharmaceutical Advisory Council (2002). Guidelines for Medication Management in Residential Aged Care Facilities. 3rd edn. Canberra: Commonwealth of Australia.
Australian Senate (1995). Psychotherapeutic Medication in Australia: Report of the Senate Community Affairs References Committee. Canberra: Australian Government Printing Service.
Avorn, J. et al. (1992). A randomised trial of a program to reduce the use of psychoactive drugs in nursing homes. New England Journal of Medicine, 327, 168173
Ballard, C., Waite, J. and Birks, J. (2006). Atypical antipyschotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews, 1, CD003476.
Ballard, C. et al. (2009). The dementia antipsychotic withdrawal trial (DART-AD): long -term follow-up of a randomised placebo-controlled trial. Lancet Neurology, 8, 151157.
Conn, D. and Madan, R. (2006). Use of sleep-promoting medications in nursing home residents. Drugs and Aging, 23, 271287.
Crotty, M. et al. (2004). An outreach intervention to implement evidence based practice in residential care: a randomised controlled trial. BMC Health Services Research, 4, 6.
Department of Health and Ageing (2007). Aged Care Homes: Residential Medication Management Review. Available at
Draper, B. et al. (2001). Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances. International Psychogeriatrics, 13, 107120.
Fonad, E., Robins Wahlin, T., Winblad, R., Emami, A. and Sandmark, H. (2008). Falls and fall risk among nursing home residents. Journal of Clinical Nursing, 17, 126134.
International Psychogeriatric Association (2004). Primary Care Physicians Guide to BPSD. Available at (last accessed 8 September 2009).
Madhusoodanan, S. and Bogunovic, O. (2004). Safety of benzodiazepines in the geriatric population. Expert Opinion Patient Safety, 3, 485493.
Monette, J. et al. (2008). Effect of an interdisciplinary educational program on antipsychotic prescribing among nursing home residents with dementia. International Journal of Geriatric Psychiatry, 23, 574579.
Nishtala, P., McLachlan, A., Bell, J. and Chen, T. (2008). Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. American Journal of Geriatric Psychiatry, 16, 621632.
Ray, W., Blazer, D., Schaffner, W. and Federspiel, C. (1987). Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit. American Journal of Public Health, 77, 14481450.
Roberts, M. et al. (2001). Outcomes of a randomised controlled trial of a clinical pharmacy intervention in 52 nursing homes. British Journal of Clinical Pharmacology, 51, 257265.
Royal Australian College of General Practitioners (2005). Medical care of older persons in residential aged care facilities. Silver Book National Taskforce, 4th edn. Available at (last accessed 8 September 2009).
Royal Australian College of General Practitioners (2000). Guidelines for the Rational Use of Benzodiazepines. Available at (last accessed 8 September 2009).
Schmidt, I., Claesson, C., Westerholm, B., Nilsson, L. and Svarstad, B. (1998). The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. Journal of the American Geriatrics Society, 46, 7782.
Schneider, L., Dagerman, M. and Insel, P. (2006). Efficacy and Adverse effects of atypical Antipsychotics for dementia: Meta-analysis of randomised, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191210.
Snowdon, J., Day, S. and Baker, W. (2005). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 17, 110.
Westbury, J., Jackson, S. and Peterson, G. (2009). Psycholeptic use in Tasmanian aged care homes. International Journal of Clinical Pharmacy and Therapeutics. In press.
Woodward, M. (2006). Hypnosedatives and the elderly – are we doing enough to reduce risk and improve outcomes? Journal of Pharmacy Practice and Research, 36, 5.


An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project

  • Juanita Westbury (a1), Shane Jackson (a1), Peter Gee (a1) and Gregory Peterson (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed